Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6140119

Title:Expression of estrogen receptors in type I and type II human breast epithelial cells
Inventors:Chang, Chia-Cheng; Okemos, MI, USA
Summary:This invention introduces novel purified type I human breast epithelial cells expressing a truncated human estrogen receptor and capable of forming budding or ductal structures when cultured in a matrix of reconstituted basement membrane components. Therapeutic applications in the treatment of anemia and leukemia are provided.
Abstract:A method is described for culturing morphologically and antigenically distinguishable types of normal human breast epithelial cells (HBEC) derived from reduction mammoplasty. Type I HBEC showed luminal and stem cell characteristics i.e. the ability to form budding/ductal structures when cultured on MATRIGEL and expressed a variant ER (.about.48 Kd) which has a deletion in the DNA binding domain (exon 2). In contrast, Type II HBEC with basal epithelial phenotype are ER-negative when cultured on MATRIGEL. Simian virus 40 (SV40) transformed Type I and Type II HBEC lines also expressed the variant ER. Tumors formed in athymic nude mice by in vitro transformed tumorigenic Type I cell lines, however, expressed a high level of wild type ER which was undetectable in these cells grown in vitro before and after tumor formation. Thus, there appears to be a differentional ER mRNA splicing between the in vitro and in vivo milieu.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6140119
Application Number:US1997000790659
Date Filed:29/01/1997
Date Published:31/10/2000
Assignee:Michigan State University, East Lansing, MI, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/18/2021